capAI PLC - Extension of Licence and Option Agreements
THIS ANNOUNCEMENT ("ANNOUNCEMENT") AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF THE DOMESTIC LAW OF THE

capAI plc
(the "Company" and, together with its subsidiaries and subsidiary undertakings, the "Group" or "capAI")
Extension of Licence and Option Agreements for Author42, Movie42 and Gamers42
capAI (LSE: CPAI, OTCQB: CPIQF), the applied artificial intelligence ("AI") venture platform, is pleased to announce that it has agreed with R42 Group LLC ("R42") to extend the licence and option arrangements in place across its capMedia platform portfolio, comprising Author42, Movie42 (formerly Creator42) and Gamers42 (formerly Game42), so as to provide additional time for the continued development and commercialisation of each platform.
Background
The Company holds separate licence and option agreements with R42 in respect of Author42 (dated
Under the Author42 LOA and the Movie42 LOA, capAI's licence period (the "Licence Period") runs for 12 months from the relevant commencement date, being
Gamers42 remains under development by R42, and the Gamers42 LOA provides that capAI's Licence Period will only commence upon delivery by R42 of a completion notice confirming that Gamers42 has reached MVP readiness. That completion notice has not yet been delivered. The Gamers42 LOA provided for a longstop date of
Extension of Licence Periods and Longstop Date
The Company's board of directors (the "Board") has agreed with R42 to align the LOAs around a common extended date, and the Company and R42 have accordingly entered into separate deeds of amendment on
· Author42: the Licence Period has been extended so as to expire at
· Movie42: the Licence Period has been extended so as to expire at
· Gamers42: the Longstop Date by which R42 must deliver the completion notice has been extended to
Other than the amendments described above, the terms of each LOA remain unchanged, including the
Rationale
The Board believes that extending the LOAs provides capAI with the additional time needed to continue developing, testing and commercialising Author42, Movie42 and Gamers42, consistent with the Company's disciplined, capital-efficient venture model described in its prior announcements. Shareholders should note that there can be no guarantee that the Company will ultimately exercise its Option under any LOA, and that decisions to do so will continue to be made selectively, having regard to technical progress, market potential and capital allocation considerations.
Related Party Considerations
R42 is a venture capital firm founded and led by Professor
Commenting, Professor
"Author42, Movie42 and Gamers42 are all progressing well, and this extension simply gives each platform the runway it needs to keep building a genuine commercial user base before we take any decision on exercising our options. R42 remains fully committed to development of the capMedia portfolio, and this extension reflects the strength of the ongoing alliance with capAI."
Further updates will be provided in due course.
For the purposes of
Enquiries
Company:
capAI plc hello@capaiplc.com
Broker:
AlbR Capital Limited Tel: +44 (0) 207 469 0930
Important Legal Information
The information contained in this Announcement is for background purposes only and does not purport to be full or complete, nor does this Announcement constitute or form part of any invitation or inducement to engage in investment activity. No reliance may be placed by any person for any purpose on the information contained in this Announcement or its accuracy, fairness or completeness. The contents of this Announcement are not to be construed as legal, financial or tax advice.
This Announcement does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities, nor shall it (or any part of it), or the fact of its distribution, form the basis of, or be relied on in connection with, any contract therefor.
This Announcement may include forward-looking statements, which are based on current expectations and projections about future events, including about the Group's operations, strategy, financial performance, development milestones, and the future prospects of its business divisions, including capMedia Inc, capMedical Inc, capMedia (UK) Ltd and capMedical (UK) Ltd. These statements may include, without limitation, any statements preceded by, followed by or including words such as "target", "believe", "expect", "aim", "intend", "may", "anticipate", "estimate", "plan", "project", "will", "can have", "likely", "should", "would", "could" and any other words and terms of similar meaning or the negative thereof.
Forward-looking statements are based on current expectations and are subject to various risks and uncertainties that could cause actual outcomes to differ materially. These risks include, but are not limited to: successful execution of definitive agreements; regulatory approvals; development timelines; market acceptance; technological shifts; and broader economic conditions. No representation or warranty is made or will be made that any forward-looking statement will come to pass, and no assurance can be given that any forward-looking statement will prove accurate. Except as required by law, capAI undertakes no obligation to revise or update any forward-looking statement. The forward-looking statements in this Announcement speak only as at the date of this Announcement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE